[Automatic detection model of hypertrophic cardiomyopathy based on deep convolutional neural network]

Yuxiang Bu1, Xingzeng Cha1, Jinling Zhu1

  • 1School of Electronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu 610054, P. R. China.

Insights

This study introduces a deep learning approach using convolution neural networks (CNNs) for automatic hypertrophic cardiomyopathy (HCM) detection from single-lead electrocardiogram (ECG) signals. The method achieved high accuracy, aiding in early risk assessment and large-scale screening.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Artificial Intelligence in Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) diagnosis is crucial for sudden cardiac death risk stratification and genetic screening.
  • Conventional multi-lead ECG methods have technical limitations.
  • Early and accurate detection of HCM is essential for patient management.

Purpose of the Study:

  • To develop an automated method for hypertrophic cardiomyopathy (HCM) detection using single-lead electrocardiogram (ECG) signals.
  • To leverage deep learning, specifically convolution neural networks (CNNs), for enhanced ECG analysis.
  • To provide a tool for efficient, large-scale preliminary screening of HCM.

Main Methods:

  • Utilized single-lead ECG signals as input data.
  • Implemented R-wave peak detection, signal segmentation, and resampling per heartbeat.
  • Developed and optimized a convolution neural network (CNN) model for feature extraction and HCM classification.
  • Trained the model on a dataset of 14,459 heartbeats from public PhysioNet databases.

Main Results:

  • The optimized CNN model demonstrated high performance in detecting HCM.
  • Achieved an accuracy of 95.98%, sensitivity of 98.03%, and specificity of 95.79%.
  • The deep learning approach effectively analyzed single-lead ECG data.

Conclusions:

  • Deep learning, specifically CNNs, offers an effective method for automated HCM detection from single-lead ECG.
  • This approach overcomes limitations of traditional multi-lead ECG methods.
  • The developed method has significant potential for assisting clinicians in rapid, large-scale HCM screening.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
82
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
39
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
48